Free ₹200 worth HealthCash on app
Use HealthCash to order medicines, health products & much more
Get App

Ramistar-A (5/2.5 mg) Capsule

Manufactured byLupin Ltd.
ContainsAmlodipine (5 mg) + Ramipril (2.5 mg)
CURRENTLY UNAVAILABLE

Confused about any medicine? Just ask Practo AIFREE

50000+ health queries resolved in last month

Chat with Practo AI on Whatsapp

Not finding what you need? Ask Practo AI

FREE

Chat with Practo AI on Whatsapp

Description

Ramistar-A (5/2.5 mg) Capsule is a combination of Amlodipine and Ramipril. It is used to treat hypertension (high blood pressure). This medicine works by relaxing the heart muscles and blood vessels. This relaxation promotes the smooth flow of blood in vessels and your heart pumps blood more efficiently. Ramistar-A (5/2.5 mg) Capsule has some side effects like nausea, headache, upset stomach and change in taste. Avoid driving vehicles or operating machines and rise slowly from a sitting or lying position if you feel dizzy while on Ramistar-A (5/2.5 mg) Capsule treatment. Let your doctor know about any cough or throat irritation that does not go away. Ramistar-A (5/2.5 mg) Capsule may cause swelling in your ankles; therefore, avoid sitting for long hours and try to keep the legs at the level or above your waist. Usually, these side effects are temporary. If any of these side effects do not resolve with time or get worse, seek a doctor's consultation at the earliest. Avoid taking this medicine if you are allergic to it. Ramistar-A (5/2.5 mg) Capsule treatment should not be stopped all of a sudden as it can cause your blood pressure to rise, thereby increasing the risk of heart attack and stroke. Ramistar-A (5/2.5 mg) Capsule is safer for you, when used after sharing your entire medical and medication history (especially Aliskiren) with your doctor. Inform your doctor if you are pregnant, planning a pregnancy or are breastfeeding before taking Ramistar-A (5/2.5 mg) Capsule.

Substitutes

List of substitutes for Ramistar-A (5/2.5 mg) Capsule

Side effects

Major & minor side effects for Ramistar-A (5/2.5 mg) Capsule

Blurred vision

Sweating

Dizziness

Unusual tiredness and weakness

Back pain

Chest tightness

Increased heartbeat

Cough

Diarrhoea

Vomiting

Swelling of ankles or feet

Difficulty in breathing

Redness of face, neck, arms and chest

Muscle pain

Heartburn

Acid or sour stomach

Stomach pain

Anxiety

Uses of Ramistar-A (5/2.5 mg) Capsule

What is it prescribed for?

Hypertension

Hypertension or high blood pressure is a condition in which the force exerted by your blood on blood vessel walls is high. Ramistar-A (5/2.5 mg) Capsule is used to reduce blood pressure.
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?

    The effect of Ramistar-A (5/2.5 mg) Capsule can be observed within 1 to 2 hours of taking this medication.
  • How long do the effects of this medicine last?

    The effect of Ramistar-A (5/2.5 mg) Capsule lasts for an average duration of 24 hours.
  • Is it safe to consume alcohol while taking this medicine?

    Consumption of alcohol is not recommended during treatment with Ramistar-A (5/2.5 mg) Capsule due to the increased risk of side effects. Avoid performing any activities that require high mental alertness such as driving vehicles or operating machines.
  • Is this a habit forming medicine?

    Ramistar-A (5/2.5 mg) Capsule has no habit forming tendency.
  • Can this medicine be taken during pregnancy?

    Ramistar-A (5/2.5 mg) Capsule is not recommended for use during pregnancy as it can affect your foetus. Your doctor may prescribe a safer alternative based on your clinical condition.
  • Can this medicine be taken while breast-feeding?

    Ramistar-A (5/2.5 mg) Capsule is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

Allergy

Avoid taking Ramistar-A (5/2.5 mg) Capsule if you are allergic to this medicine. Seek medical attention if you see symptoms such as skin rash, swelling ( of face, lips, tongue, etc.), breathing difficulty, etc.

Aliskiren

Combined use of Ramistar-A (5/2.5 mg) Capsule and Aliskiren is not recommended if you have diabetes and/or kidney impairment with CrCl less than 60 ml/min. Combined use of these medicines may increase the risk of side effects.

Liver disease

Ramistar-A (5/2.5 mg) Capsule is converted into its active form by your liver. The presence of the liver disease may impair the conversion of this medicine into its active form thus leading to the accumulation of this medicine in your liver. This accumulation may worsen your liver condition. Hence, Ramistar-A (5/2.5 mg) Capsule is not recommended for use if you have active liver diseases.

Warnings for special population

Pregnancy

Ramistar-A (5/2.5 mg) Capsule is not recommended for use during pregnancy as it can affect your foetus. Your doctor may prescribe a safer alternative based on your clinical condition.

Breast-feeding

Ramistar-A (5/2.5 mg) Capsule is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical condition.

General warnings

Hypotension

Symptomatic hypotension (low blood pressure) may occur in the presence of volume depletion (excess loss of salt and fluid leading to reduced fluid volume) or when treated with other medicines used in the treatment of high blood pressure. Correct this condition before initiating treatment with Ramistar-A (5/2.5 mg) Capsule.

Hyperkalemia

Ramistar-A (5/2.5 mg) Capsule may increase the potassium levels in your blood (hyperkalemia). It should be used if you have hyperkalemia and potassium levels should be monitored regularly. Avoid potassium-rich foods (potatoes, bananas) and potassium supplements during treatment with this medicine.

Use in children

Ramistar-A (5/2.5 mg) Capsule is not recommended for use in children and adolescents less than 18 years of age as the safety and efficacy of use are not clinically established.

Cough

Ramistar-A (5/2.5 mg) Capsule may cause a persistent nonproductive cough. It is resolved when the medicine is discontinued.

Aortic stenosis

Aortic stenosis is the narrowing of the valves of your heart that regulate the blood flow between the heart chambers. Ramistar-A (5/2.5 mg) Capsule should be used with caution if you have aortic stenosis.

Kidney disease

Ramistar-A (5/2.5 mg) Capsule may cause azotemia (elevated levels of urea and other nitrogen compounds in your blood) if you have a history of severe kidney disease. Your doctor will closely monitor your kidney function or adjust the dose to use this medicine safely.

Driving and operating machines

Ramistar-A (5/2.5 mg) Capsule may cause dizziness and a decrease in blood pressure. Avoid performing any activities that require high mental alertness like driving vehicles or operating machines.

Missed Dose

If you missed a dose of Ramistar-A (5/2.5 mg) Capsule, take it as soon as you remember. If the next dose timing is near, skip the missed dose. Take your next dose at your usual time. Do not double the dose.

Overdose

If you suspect that you might have taken an overdose of Ramistar-A (5/2.5 mg) Capsule, seek medical attention at the earliest.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.

Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with Ramistar-A (5/2.5 mg) Capsule due to the increased risk of side effects. Avoid performing any activities that require high mental alertness such as driving vehicles or operating machines.

Interaction with Medicine

Itraconazole

Losartan

Corticosteroids

Rifampicin

Insulin

Nonsteroidal anti-inflammatory medicines

Disease interactions

Angioedema

Use of Ramistar-A (5/2.5 mg) Capsule is not recommended if you have a history of angioedema (swelling in the lower layer of your skin). In such cases, you may be at an increased risk of angioedema while receiving the treatment. Consult with your doctor if you have any concerns.

Cardiogenic shock

Ramistar-A (5/2.5 mg) Capsule is not recommended for use in case of cardiogenic shock ( your heart suddenly stops pumping enough blood to the body) because it may worsen your heart condition.

Food interactions

Consumption of grapefruit juice is not recommended during treatment with Ramistar-A (5/2.5 mg) Capsule due to the increased risk of adverse effects such as dizziness, muscle pain, fever and chills, headache, swelling of hands and feet, vomiting, skin rash, etc.

Lab interactions

Information not available.
Take Ramistar-A (5/2.5 mg) Capsule with or without food. It can make you feel dizzy for the first few days, so rise slowly if you have been sitting or lying down. You can also prefer taking it at bedtime to avoid dizziness throughout the day. Let your doctor know about any cough or throat irritation that does not go away. It may increase the level of potassium in the blood. Avoid taking potassium supplements and potassium-rich foods such as bananas and broccoli. Do not crush, break or chew the tablet in your mouth.

Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works

Ramistar-A (5/2.5 mg) Capsule is a combination of Amlodipine and Ramipril. Amlodipine relaxes your heart muscles and blood vessels. Ramipril relaxes the blood vessels and promotes the smooth flow of blood. Their combination is thus effective in reducing blood pressure.

Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Calcium channel blocking agents, Angiotensin converting enzyme inhibitors, ACE inhibitors with calcium channel blocking agents, Antihypertensive combinations

Schedule

Schedule H

Medicines.org.uk. 2021. Ramipril 2.5mg Tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 1 September 2021].

https://www.medicines.org.uk/emc/product/5890/smpc>

Dailymed.nlm.nih.gov. 2021. DailyMed - ramipril- Ramipril capsule. [online] Available at: < [Accessed 17 August 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8b59207a-ea5c-4697-a8b6-94c3015a00de>

Medicines.org.uk. 2021. Amlodipine 5mg tablets - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 1 September 2021].

https://www.medicines.org.uk/emc/product/4717/smpc#PRODUCTINFO>

Products.sanofi.in. 2021. [online] Available at: < [Accessed 1 September 2021].

http://products.sanofi.in/Cardace-AM.pdf>

Drugs, H., 2021. Amlodipine: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 1 September 2021].

https://medlineplus.gov/druginfo/meds/a692044.html>

Related Questions

Question:
My mom was taking Ramistar 2.5 tablet for BP for full March month and then she stopped because docto...more
Answer from Dr. Ashwin
Need to be evaluated with detailed history. Consult online for further managemen...more
Question:
Is blood pressure 140/90 acceptable for paitent already on medication for BP?Right now he is on Rami...more
Answer from Dr. Anand Lingan
If the BP is consistently high...the BP medication has to be changed or dose has...more
Question:
I have a mitral heart replacement in the year 2002 in Mumbai. since I have take warfarin, ramistar 1...more
Answer from Dr. Rajni Sharma
Need to stop ramistar and calaptin. Shift to beta blockers, metoprolol instead o...more
Question:
My mom was on medication Ramistar MXL 50 (m), Clopitab (a) and ecosprin 150 (a) and Xtor 20(n) since...more
Answer from Dr. Sheetal Aversekar
Post food blood sugar in the level between 140 and 200 is considered to be in th...more
Question:
Hi, My father under went angioplasty on last month 14th ,now he is coughing even after consulting re...more
Answer from Dr. Paramjeet Singh
Ramipril can have a side effect of cough and if it is severe then you need to co...more
Something doesn’t feel right?
Report an error

Information on this page was last updated on 1 Sep 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.